Home » FDA Clears Yale’s Saliva-Based COVID-19 Test for Emergency Use
FDA Clears Yale’s Saliva-Based COVID-19 Test for Emergency Use
The Yale School of Public Health has received an Emergency Use Authorization from the FDA for a saliva-based COVID-19 laboratory test.
The test is cheaper and less invasive than nasopharyngeal swabbing but yields similar outcomes, the university said. It said it expects labs to charge about $10 per sample.
The saliva-based test has been validated with reagents and instruments from multiple vendors, Yale said, enabling testing to continue if some vendors encounter supply-chain issues.
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May